The role of NF-κB in cancer is further supported by the findings of Paschke et al. (2016), which demonstrated that ZFP91, an oncogenic protein, activates the noncanonical NF-κB pathway, suggesting a complex interplay between various signaling mechanisms in prostate cancer biology [7]. This evidence concerns the gene NFKB1 and prostate carcinoma.